Enterin’s ENT-01 Restored Bowel Motility in Constipated Parkinson’s Patients
Daily treatment with tablets of ENT-01, an investigational therapy for Parkinson’s disease, is safe and may restore patients’ bowel movements,…
Articles by Ana Pena, PhD
FDA Approves Myobloc, Injection Treatment for Chronic Drooling
Myobloc (rimabotulinumtoxinB) injections are approved by the U.S. Food and Drug Administration (FDA) to treat adults with chronic sialorrhea,…
Low Vitamin D Levels Linked to Added Falls, More Sleep Problems, Depression, Study Shows
Low vitamin D levels are associated with a greater tendency for falls, sleep problems, anxiety, and depression in…
Resistance Training Reduces Depressive Symptoms in Older PD Patients, Trial Shows
Twenty weeks of resistance training significantly decreases depression symptoms and improves quality of life in older people with…
IPX203 Extended-Release Capsules Reduce ‘Off’ Time in Advanced Parkinson’s, Trial Shows
Impax Laboratories‘ investigational carbidopa-levodopa extended-release capsules, IPX203, are better than immediate-release tablets at maintaining…
Sexually Active Life Linked to ‘Milder’ Disease Progression in Men with Early Stage Parkinson’s, Study Finds
An active sexual life is associated with less severe motor and non-motor disability and a better quality of…
Endurance Exercise May Help Manage Cortisol Levels in Parkinson’s Patients, Study Suggests
Doing high-intensity endurance exercise reduces morning cortisol levels in patients with Parkinson’s disease, which may have an impact…
Parkinson’s Medications Relieve Central Pain Better than Other Types of Pain, Study Finds
Treatment with standard Parkinson’s therapies, such as levodopa or dopamine agonists, can…
Early Involvement of Caudate Brain Region Linked to Worse Prognosis in Parkinson’s Patients, Study Finds
Almost half of people in the early stages of Parkinson’s disease already have signs of neurodegeneration…
Levodopa-Sparing Medications May Help Patients in Early Stages of Parkinson’s, Study Suggests
Neurologists treating patients with early-stage Parkinson’s disease should prescribe more often therapies that spare patients from starting levodopa too…